Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q.
Several genomewide screens have been performed to identify novel loci predisposing to unfavorable serum lipid levels and coronary heart disease (CHD). We hypothesized that the accumulating data of these screens in different study populations could be combined to verify which of the identified loci truly harbor susceptibility genes. The power of this strategy has recently been demonstrated with other complex diseases, such as inflammatory bowel disease and asthma. We assessed the largely unknown genetic background of CHD by investigating the most common dyslipidemia predisposing to CHD, familial combined hyperlipidemia (FCHL), affecting 1%-2% of Western populations and 10%-20% of families with premature CHD. To be able to perform a combined data analysis, we unified the diagnostic criteria for FCHL and its component traits and combined the data from two genomewide scans performed in two populations, the Finns and the Dutch. As a result of our pooled data analysis, we identified three chromosomal regions, on chromosomes 2p25.1, 9p23, and 16q24.1, exceeding the statistical significance level of a LOD score >2.0. The 2p25.1 region was detected for the FCHL trait, and the 9p23 and 16q24.1 regions were detected for the low high-density lipoprotein cholesterol (HDL-C) trait. In addition, the previously recognized 1q21 region also obtained additional support in the other study sample, when the triglyceride trait was used. Analysis of the 16q24.1 region resulted in a statistically significant LOD score of 3.6 when the data from Finnish families with low HDL-C were included in the analysis. To search for the underlying gene in the 16q24.1 region, we investigated a novel functional and positional candidate gene, helix/forkhead transcription factor (FOXC2), by sequencing and by genotyping of two single-nucleotide polymorphisms in the families.
Pajukanta
Päivi
P
Department of Human Genetics, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA 90095, USA. ppajukanta@mednet.ucla.edu
Allayee
Hooman
H
Krass
Kelly L
KL
Kuraishy
Ali
A
Soro
Aino
A
Lilja
Heidi E
HE
Mar
Rebecca
R
Taskinen
Marja-Riitta
MR
Nuotio
Ilpo
I
Laakso
Markku
M
Rotter
Jerome I
JI
de Bruin
Tjerk W A
TW
Cantor
Rita M
RM
Lusis
Aldons J
AJ
Peltonen
Leena
L
D008076:Cholesterol, HDL / Q000097:blood*; D002874:Chromosome Mapping; D002885:Chromosomes, Human, Pair 16; D003327:Coronary Disease / Q000453:epidemiology / Q000235:genetics*; D004276:DNA, Satellite / Q000235:genetics; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D015894:Genome, Human; D005838:Genotype; D005858:Germany; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000235:genetics*; D008126:Lod Score; D009426:Netherlands; D012307:Risk Factors
D008076:Cholesterol, HDL; D004276:DNA, Satellite; D005819:Genetic Markers